U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
123781123781[Trial of device that is not approved or cleared by the U.S. FDA]WithheldNo Results Availablehttps://ClinicalTrials.gov/show/NCT00944411
123782123782Impact of Targeted Zinc Fortification Programs on Plasma Zinc ConcentrationCompletedNo Results AvailableZinc DeficiencyDietary Supplement: Zinc fortified food|Dietary Supplement: Zinc supplement|Other: Placebo supplement|Dietary Supplement: Non-fortified foodhttps://ClinicalTrials.gov/show/NCT00944398
123783123783Effects of Ulinastatin on Myocardial Protection and Blood Loss in Patients Undergoing Aortic Valve ReplacementCompletedNo Results AvailableAbnormal Aortic ValveDrug: ulinastatinhttps://ClinicalTrials.gov/show/NCT00944385
123784123784Study to Evaluate the Effect of Age (Geriatric) and Kidney Function on the Safety, Efficacy and Pharmacokinetics of OctreoScan in Patients Who Have New or Recurrent TumorsTerminatedNo Results AvailableSolid TumorsDrug: Indium In-111 pentetreotidehttps://ClinicalTrials.gov/show/NCT00944372
123785123785Impact of Preventive and Therapeutic Zinc Supplementation Programs Among Young ChildrenCompletedNo Results AvailableZinc Deficiency|Diarrhea|MalariaDietary Supplement: Daily preventive Zn; placebo treatment|Dietary Supplement: Therapeutic Zn; daily placebo|Dietary Supplement: Intermittent Zn; placebo treatment|Other: Surveillance control grouphttps://ClinicalTrials.gov/show/NCT00944359
123786123786Study to Evaluate the Bioequivalence of a Test Tablet Formulation of Metformin HCl (1000 mg), Compared to an Equivalent Dose of a Commercially Available Reference Drug Product (Glucophage®, Bristol-Myers Squibb Company) in Fed, Healthy, Adult SubjectsCompletedNo Results AvailableHealthyDrug: Metformin HClhttps://ClinicalTrials.gov/show/NCT00944346
123787123787Second Generation" Drug-Eluting Stents Implantation Followed by Six Versus Twelve-Month - Dual Antiplatelet TherapyTerminatedNo Results AvailableAngina Pectoris|Silent IschemiaDrug: Clopidogrel|Drug: Clopidogrelhttps://ClinicalTrials.gov/show/NCT00944333
123788123788Pharmacogenetics of Antifolate Disease Modifying Anti-Rheumatic Drugs in Rheumatoid Arthritis in TaiwanCompletedNo Results AvailableRheumatoid Arthritishttps://ClinicalTrials.gov/show/NCT00944320
123789123789Effect of Antacids on the Pharmacokinetics of RaltegravirCompletedNo Results AvailableHIV InfectionsDrug: raltegravir|Drug: antacidhttps://ClinicalTrials.gov/show/NCT00944307
123790123790Efficacy and Safety Study of Binodenoson in Assessing Cardiac IschemiaCompletedNo Results AvailableCoronary Artery DiseaseDrug: binodenoson|Drug: adenosinehttps://ClinicalTrials.gov/show/NCT00944294
123791123791Optimal Amount of Zinc to Include in a Lipid-based Nutrient Supplement (LNS)CompletedNo Results AvailableMalnutritionDietary Supplement: LNS-Zn5|Dietary Supplement: LNS-Zn10|Dietary Supplement: LNS-Zn0|Dietary Supplement: Suppl-Zn5https://ClinicalTrials.gov/show/NCT00944281
123792123792Efficacy and Tolerability Study to Treat Mild and Moderate AnxietyNot yet recruitingNo Results AvailableAnxiety|Efficacy|TolerabilityDrug: Passiflora, Crataegus e Salixhttps://ClinicalTrials.gov/show/NCT00944268
123793123793Pharmacogenetics of Antifolate Drugs in Autoimmune Diseases in TaiwanCompletedNo Results AvailableRheumatoid Arthritishttps://ClinicalTrials.gov/show/NCT00944255
123794123794Bioequivalence Study of Sertraline 100 mg Tablet and ZOLOFT Following a 100 mg Dose in Healthy Subjects Under Fasting ConditionsCompletedNo Results AvailableHealthyDrug: Sertraline|Drug: Sertraline Hydrochloridehttps://ClinicalTrials.gov/show/NCT00944242
123795123795The Effect of Omega-3 Polyunsaturated Fatty Acids in Congestive Heart FailureTerminatedNo Results AvailableHeart FailureDrug: LOVAZA (Omega-3)|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00944229
123796123796Efficacy and Safety of Salkera Emollient Foam in the Treatment of Moderate to Severe Keratosis Pilaris, a Prospective StudyTerminatedNo Results AvailableKeratosis PilarisDrug: Salkera Emollient Foamhttps://ClinicalTrials.gov/show/NCT00944216
123797123797Efficacy of Ipomea Pes-caprae Ointment as an add-on Therapy in Patient With Jellyfish DermatitisRecruitingNo Results AvailableJellyfish Dermatitis|Jellyfish VenomsDrug: Ipomea pes-caprae ointmenthttps://ClinicalTrials.gov/show/NCT00944203
123798123798TakeCharge: Telephone Delivered Self-management Intervention for People With Multiple Sclerosis (MS)CompletedNo Results AvailableMultiple SclerosisBehavioral: Self-management intervention|Behavioral: Educationhttps://ClinicalTrials.gov/show/NCT00944190
123799123799Study to Evaluate the Bioequivalence of a Test Tablet Formulation of Metformin HCl (1000 mg), Compared to an Equivalent Dose of a Commercially Available Reference Drug Product (Glucophage®, Bristol-Myers Squibb Company) in Fasted, Healthy, Adult SubjectsCompletedNo Results AvailableHealthyDrug: Metformin HClhttps://ClinicalTrials.gov/show/NCT00944177
123800123800Primary Care Obesity Prevention and TreatmentCompletedNo Results AvailableObesityBehavioral: Healthy eating and physical activity|Behavioral: Safety and injury preventionhttps://ClinicalTrials.gov/show/NCT00944164
123801123801Continuous Transversus Abdominis Plane Nerve Block for Postoperative AnalgesiaTerminatedNo Results AvailableIncisional PainProcedure: TAP Catheter and Infusion of Study Solutionhttps://ClinicalTrials.gov/show/NCT00944151
1238021238028-week Pilot Study of Relaxation for Weight Loss in Adults With Chronic Kidney DiseaseCompletedNo Results AvailableObesityBehavioral: Relaxation methodshttps://ClinicalTrials.gov/show/NCT00944138
123803123803Dual Site Left Ventricular (LV) PacingCompletedNo Results AvailableCongestive Heart Failure|LV DysfunctionDevice: Dual Site LV Pacing vs. BiV Pacinghttps://ClinicalTrials.gov/show/NCT00944125
123804123804Restrictive and Liberal Transfusion Strategies in Intensive CareCompletedNo Results AvailableIntensive Care|Blood Transfusion|AnemiaBiological: Restrictive RBC Transfusion|Biological: Liberal RBC Transfusionhttps://ClinicalTrials.gov/show/NCT00944112
123805123805Lifestyle, Eating, and Activity PatternsCompletedNo Results AvailableOverweight|ObesityBehavioral: Behavioral weight loss interventionhttps://ClinicalTrials.gov/show/NCT00944099
123806123806Oxygen Concentration Should be Kept at the Lowest Possible Level During RecruitmentCompletedNo Results AvailableLaparoscopic SurgeryOther: Recruitment Manoeuvrehttps://ClinicalTrials.gov/show/NCT00944086
123807123807Peds Sanofi H1N1 Influenza Vaccine Administered at Two Dose LevelsCompletedHas ResultsInfluenzaBiological: Influenza Virus Vaccine, Monovalent A/H1N1 A/California/7/2009 NYMC X-179Ahttps://ClinicalTrials.gov/show/NCT00944073
123808123808A Pilot Study of Diabetes Risk Reduction Program With WIC Mothers(The Special Supplemental Nutrition Program for Women, Infants, and Children) Overweight WIC MothersCompletedNo Results AvailablePrevention of Weight GainOther: lifestyle interventionhttps://ClinicalTrials.gov/show/NCT00944060
123809123809Evaluate Trastuzumab Plus Standard Chemotherapy Given Before Surgery in Breast Cancer Patients With Low HER 2 ExpressionActive, not recruitingNo Results AvailableBreast CancerDrug: nab-paclitaxel|Drug: trastuzumab|Drug: Doxorubicin|Drug: cyclophosphamidehttps://ClinicalTrials.gov/show/NCT00944047
123810123810Safety, Tolerability and Immunogenicity of Meningococcal B Recombinant Vaccine Administered as Booster Dose at 12, 18 or 24 Months of Age in Toddlers (12-24 Months) Primed With a Three-Dose Immunization Series as Infants in Study V72P12CompletedNo Results AvailableMeningococcal Disease|Meningococcal MeningitisBiological: rMenB+OMV NZ with routine vaccinations|Biological: rMenB+OMV NZ with routine vaccinations|Biological: rMenB+OMV NZ|Biological: rMenB+OMV NZ|Biological: rMenB+OMV NZ with routine vaccinations|Biological: rMenB+OMV NZ with routine vaccinations|Biological: two doses of rMenB+OMV NZ|Biological: rMenB+OMV NZ with routine vaccinations|Biological: two doses of rMenB+OMV NZ|Biological: rMenB+OMV NZ|Biological: two doses of rMenB+OMV NZ|Biological: rMenB+OMV NZ with routine vaccinationshttps://ClinicalTrials.gov/show/NCT00944034

* Görseller ve İçerik tekif hakkına sahip olabilir